Supriya Lifescience Limited (BOM:543434)
India
· Delayed Price · Currency is INR 728.15
+3.95 (0.55%)
At close: Jul 2, 2025
Supriya Lifescience Revenue
In the fiscal year ending March 31, 2025, Supriya Lifescience had annual revenue of 6.96B INR with 22.11% growth. Supriya Lifescience had revenue of 1.84B in the quarter ending March 31, 2025, with 16.39% growth.
Revenue
6.96B
Revenue Growth
+22.11%
P/S Ratio
8.50
Revenue / Employee
15.55M
Employees
448
Market Cap
59.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |